Biopol Chemicals IPO Day 1: Muted Demand, Zero GMP on Opening Day

The Biopol Chemicals Ltd SME IPO opened for public subscription on Friday, 6 February 2026, with early subscription figures showing limited investor interest and a neutral grey market stance.

📅 IPO Timeline & Price Band

• IPO Opened: 6 February 2026
• IPO Closes: 10 February 2026
• Basis of Allotment Expected: 11 February 2026
• Refunds Initiated: 12 February 2026
• Shares Credited to Demat: 12 February 2026
• Listing Date: 13 February 2026 on NSE SME.
• Price Band: ₹102 to ₹108 per share.
• Issue Size: Around ₹31.26 crore via a fresh issue of 28,94,400 shares.
• Lot Size: 1,200 shares (Retail minimum 2 lots = 2,400 shares, ~₹2,59,200 investment at upper band).

📉 Day 1 Subscription Status

• By mid-day on 6 February 2026, the IPO was subscribed at ~40% overall, indicating weak initial demand.
  • Retail portion: ~36% subscribed.
  • Non-Institutional Investors (NIIs): ~4% subscribed.

⚪ Grey Market Premium (GMP)

• On Day 1, the grey market premium was ₹0, suggesting neutral to low expectations of listing gains.

🏭 Company & Business Profile
Biopol Chemicals operates in the manufacturing and distribution of specialty chemicals, including silicones, emulsifiers, biochemicals and polyelectrolytes, serving industries such as textiles, home care, agriculture and industrial chemicals. The company’s product range includes 66 chemical products, and it follows a B2B model, supplying to institutional clients.

📌 Use of IPO Proceeds
According to company disclosures, the funds raised will be used for:

• Acquisition of industrial land,
• Repayment or prepayment of certain borrowings, and
• General corporate purposes.

📊 Investor Takeaway
The subdued Day 1 subscription and nil GMP reflect cautious investor sentiment at the start of bidding. Market watchers will be closely watching subscription momentum through 10 February 2026 and any shifts in grey market pricing ahead of the expected 13 February 2026 listing.